23andMe’s FDA Battle Provokes Furious Debate
Medical researchers, genomics experts, and industry pundits took wildly divergent points of view in a media storm that erupted last week over FDA’s stern letter ordering 23andMe to stop marketing its Personal Genome Service. The...